(Q29615542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

MAP kinase signalling pathways in cancer (English)

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17496922

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Walter Kolch

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Dhillon AS

series ordinal

1

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17496922

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Hagan S

series ordinal

2

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17496922

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17496922

30 December 2019

language of work or name

1 reference

30 April 2017

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17496922

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

26

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17496922

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

22

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17496922

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

3279-3290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Mechanisms of regulating the Raf kinase family

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Mutations of the BRAF gene in human cancer

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Signal transduction by the JNK group of MAP kinases

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Untying the regulation of the Raf-1 kinase

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Targeting RAS signalling pathways in cancer therapy

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Guilty as charged: B-RAF is a human oncogene

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

1 May 2017

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Coordinating ERK/MAPK signalling through scaffolds and inhibitors

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

BRAFE600-associated senescence-like cell cycle arrest of human naevi

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Regulation of MAP Kinase Signaling Modules by Scaffold Proteins in Mammals

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Raf-1 sets the threshold of Fas sensitivity by modulating Rok-alpha signaling

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Regulation and role of Raf-1/B-Raf heterodimerization

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

1 May 2017

RHO-GTPases and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

BRAF mutation predicts sensitivity to MEK inhibition

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

The RAF proteins take centre stage

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

Phorbol esters stimulate the phosphorylation of c-Jun but not v-Jun: regulation by the N-terminal delta domain

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

p38 MAPK in development and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Mechanism of p38 MAP kinase activation in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

NF-kappaB and JNK: an intricate affair

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

p38 MAP kinase's emerging role as a tumor suppressor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Amino-terminal-derived JNK fragment alters expression and activity of c-Jun, ATF2, and p53 and increases H2O2-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Low levels of glutathione peroxidase 1 activity in selenium-deficient mouse liver affect c-Jun N-terminal kinase activation and p53 phosphorylation on Ser-15 in pro-oxidant-induced aponecrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Essential role for oncogenic Ras in tumour maintenance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Targeting chaperones in transformed systems--a focus on Hsp90 and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

RAS and RHO GTPases in G1-phase cell-cycle regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

p38 Mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Regulation of Raf-1 by direct feedback phosphorylation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

EGF induced SOS phosphorylation in PC12 cells involves P90 RSK-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Raf-1 regulates Rho signaling and cell migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Cell cycle arrest and reversion of Ras-induced transformation by a conditionally activated form of mitogen-activated protein kinase kinase kinase 3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

JNK: a killer on a transcriptional leash

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

JNK targets p53 ubiquitination and degradation in nonstressed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

ERK and beyond: insights from B-Raf and Raf-1 conditional knockouts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Sorafenib: scientific rationales for single-agent and combination therapy in clear-cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Negative regulation of MAPKK by phosphorylation of a conserved serine residue equivalent to Ser212 of MEK1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Ras proteins: different signals from different locations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Ras plasma membrane signalling platforms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

MAP kinases and cell migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Cellular transformation and malignancy induced by ras require c-jun

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Suppression of Ras-stimulated transformation by the JNK signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Targeting the ERK signaling pathway in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Functions of the MAPK family in vertebrate-development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

MC1R germline variants confer risk for BRAF-mutant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Role of the p38 MAPK pathway in cisplatin-based therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Determinants of BRAF mutations in primary melanomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Requirement of Ras-GTP-Raf Complexes for Activation of Raf-1 by Protein Kinase C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Compartmentalized Ras/MAPK signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

MAPK signal specificity: the right place at the right time

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Molecular interpretation of ERK signal duration by immediate early gene products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Homozygous deletion of MKK4 in ovarian serous carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Conferring specificity on the ubiquitous Raf/MEK signalling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

p38 MAP kinase: a convergence point in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

NF-kappaB as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Compartmentalized signalling of Ras.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

High frequency of BRAF mutations in nevi

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Role of MAP kinase in tumor progression and invasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Poor Survival Associated with theBRAFV600E Mutation in Microsatellite-Stable Colon Cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Mitogen-activated protein kinases: specific messages from ubiquitous messengers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Control of cell cycle progression by c-Jun is p53 dependent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Targeting the mitogen-activated protein kinase cascade to treat cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Inhibitors of the HSP90 molecular chaperone: current status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

BRAF mutations are detectable in conjunctival but not uveal melanomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

The absence of NF-kappaB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

KSR modulates signal propagation within the MAPK cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

A subtle change in p38 MAPK activity is sufficient to suppress in vivo tumorigenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

ERK MAP kinase in G cell cycle progression and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Suppressed MKP-1 is an independent predictor of outcome in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Role of Jun and Jun kinase in resistance of cancer cells to therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

The JNK signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

BAY 43-9006: preclinical data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

The functional interactions between the p53 and MAPK signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Phosphorylation of 338SSYY341 regulates specific interaction between Raf-1 and MEK1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Activation and signaling of the p38 MAP kinase pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210421

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210421

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17496922

30 April 2017

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17496922%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 December 2019

1002864504

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17496922

3 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017